Literature DB >> 7508459

Conservation of a protective surface antigen of Tritrichomonas foetus.

J S Ikeda1, R H BonDurant, C M Campero, L B Corbeil.   

Abstract

Bovine trichomoniasis is a sexually transmitted disease caused by the flagellated protozoan Tritrichomonas foetus. A protective surface antigen was previously identified and immunoaffinity purified from T. foetus isolate D1 with cross-reactive monoclonal antibodies (MAbs) TF1.15 and TF1.17 (BonDurant, R. H., R. R. Corbeil, and L. B. Corbeil, Infect. Immun. 61:1385-1394, 1993). This antigen elicited antibody responses in the serum and cervicovaginal mucus of heifers. Thus, it may be useful as an immunodiagnostic reagent as well as a subunit vaccine. Conservation of the antigen in all strains would be crucial for either application. We investigated the conservation of this antigen among 36 isolates of T. foetus from Argentina, Costa Rica, and the United States using MAbs TF1.15 and TF1.17 in an enzyme-linked immunosorbent assay. MAb TF1.17 reacted with 32 of the 36 isolates, whereas MAb TF1.15 reacted with all of the isolates tested. One of the isolates which did not react with MAb TF1.17 (i.e., D1#3) was investigated further by Western blotting (immunoblotting) to determine the reason for the lack of reactivity with one of the two cross-reactive MAbs. The antigenic band that was reactive with MAb TF1.15 had a molecular mass slightly lower than that of the corresponding band from isolate D1, which reacted with both MAbs TF1.15 and TF1.17. Thus, at least a major portion of the antigen appeared to be conserved. This was confirmed in a study of heifers infected with isolate D1#3. The vaginal immunoglobulin A antibodies of these infected heifers reacted with the antigen of isolate D1 that was immunoaffinity purified with MAb TF1.17. Therefore, even though the epitope recognized by MAb TF1.17 was missing in the challenge isolate (D1#3), the heifers developed an immune response to the rest of the molecule. These results indicate that the major portion of the previously described protective antigen is conserved in different isolates of T. foetus. This portion contains the epitope that reacts with MAb TF1.15. Most isolates express the whole antigen, which possesses both TFl.15 and TF1.17 epitopes, but the few isolates that are missing the portion containing the TF1.17 epitope may still elicit an immune reponse to the conserved portion. Thus, the protective surface antigen is promising for use in immunodiagnosis or vaccination against bovine trichomoniasis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7508459      PMCID: PMC266404          DOI: 10.1128/jcm.31.12.3289-3295.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Clinical evaluation of the efficacy of inoculating cattle with a vaccine containing Tritrichomonas foetus.

Authors:  W G Kvasnicka; D Hanks; J C Huang; M R Hall; D Sandblom; H J Chu; L Chavez; W M Acree
Journal:  Am J Vet Res       Date:  1992-11       Impact factor: 1.156

2.  Early pathogenesis and pathology of Tritrichomonas foetus infection in virgin heifers.

Authors:  I M Parsonson; B L Clark; J H Dufty
Journal:  J Comp Pathol       Date:  1976-01       Impact factor: 1.311

3.  Investigations of the incidence of bovine trichomoniasis in nevada and of the efficacy of immunizing cattle with vaccines containing Tritrichomonas foetus.

Authors:  W G Kvasnicka; R E Taylor; J C Huang; D Hanks; R J Tronstad; A Bosomworth; M R Hall
Journal:  Theriogenology       Date:  1989-05       Impact factor: 2.740

4.  Prevalence of trichomoniasis among California beef herds.

Authors:  R H BonDurant; M L Anderson; P Blanchard; D Hird; C Danaye-Elmi; C Palmer; W M Sischo; D Suther; W Utterback; B J Weigler
Journal:  J Am Vet Med Assoc       Date:  1990-05-15       Impact factor: 1.936

5.  Trichomonas vaginalis surface proteinase activity is necessary for parasite adherence to epithelial cells.

Authors:  R Arroyo; J F Alderete
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

6.  Control of trichomoniasis in a large herd of beef cattle.

Authors:  B L Clark; I M Parsonson; M B White; J C Banfield; J S Young
Journal:  Aust Vet J       Date:  1974-10       Impact factor: 1.281

7.  Observations on the incidence and distribution of serotypes of Tritrichomonas foetus in beef cattle in north-eastern Australia.

Authors:  D P Dennett; R L Reece; J O Barasa; R H Johnson
Journal:  Aust Vet J       Date:  1974-10       Impact factor: 1.281

8.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

9.  Characterization of Tritrichomonas foetus antigens by use of monoclonal antibodies.

Authors:  J L Hodgson; D W Jones; P R Widders; L B Corbeil
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

10.  Immunization of virgin cows with surface antigen TF1.17 of Tritrichomonas foetus.

Authors:  R H BonDurant; R R Corbeil; L B Corbeil
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

View more
  4 in total

1.  Serological response to in vitro-shed antigen(s) of Tritrichomonas foetus in cattle.

Authors:  R H Bondurant; K A van Hoosear; L B Corbeil; D Bernoco
Journal:  Clin Diagn Lab Immunol       Date:  1996-07

2.  Bovine vaginal antibody responses to immunoaffinity-purified surface antigen of Tritrichomonas foetus.

Authors:  J S Ikeda; R H BonDurant; L B Corbeil
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

3.  Antibodies to Trichomonas vaginalis surface glycolipid.

Authors:  F D Bastida-Corcuera; B N Singh; G C Gray; P D Stamper; M Davuluri; K Schlangen; R R Corbeil; L B Corbeil
Journal:  Sex Transm Infect       Date:  2013-06-19       Impact factor: 3.519

Review 4.  Vaccines against sexually transmitted diseases.

Authors:  Lynette B Corbeil; Carlos M Campero; Jack C Rhyan; Robert H BonDurant
Journal:  Reprod Biol Endocrinol       Date:  2003-12-02       Impact factor: 5.211

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.